Fig. 3

Clinical outcomes of patients with dilated cardiomyopathy (DCM) harboring TTN, LMNA, and MYH7 variants. A. The incidence of life-threatening arrhythmia events was significantly higher in patients with DCM harboring LMNA variants; B. The need for VAD insertion or ECMO support in patients with DCM harboring LMNA variants was higher than that in patients with DCM harboring MYH7 variants; C. All patients who died during the follow-up period were DCM cases harboring LMNA variants, and the mortality rate in these patients was significantly higher than that in patients harboring TTN variants. *p < 0.05 (Fisher’s exact test). Abbreviations: DCM, dilated cardiomyopathy; VAD, ventricular assist device; ECMO, extracorporeal membrane oxygenation